Results 141 to 150 of about 207,959 (157)

A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease. [PDF]

open access: yesJ Prev Alzheimers Dis
Greeley D   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy